BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jiang L, Jiang LS, Cheng NS, Yan LN. Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol 2009; 15(20): 2489-2499 [PMID: 19468999 DOI: 10.3748/wjg.15.2489]
URL: https://www.wjgnet.com/1007-9327/full/v15/i20/2489.htm
Number Citing Articles
1
Y. Li, Y. Shi, J. Chen, B. Cai, B. Ying, L. Wang. Association of polymorphisms in interleukin‐18 and interleukin‐28B with Hepatitis B recurrence after liver transplantation in Chinese Han populationInternational Journal of Immunogenetics 2012; 39(4): 346 doi: 10.1111/j.1744-313X.2012.01097.x
2
Elisabete Arrese, Miren Basaras, Sonia Blanco, Pablo Ruiz, Ramόn Cisterna. Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B Annals of Hepatology 2011; 10(4): 434 doi: 10.1016/S1665-2681(19)31509-1
3
Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng, Hong Zheng. Application of nucleoside analogues to liver transplant recipients with hepatitis BWorld Journal of Gastroenterology 2015; 21(42): 12091-12100 doi: 10.3748/wjg.v21.i42.12091
4
Claudia Della Corte, Valerio Nobili, Donatella Comparcola, Francesca Cainelli, Sandro Vento. Management of chronic hepatitis B in children: An unresolved issueJournal of Gastroenterology and Hepatology 2014; 29(5): 912 doi: 10.1111/jgh.12550
5
Payam Dindoost, Seyed Mohammad Jazayeri, Seyed Moayed Alavian. Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An UpdateHepatitis Monthly 2012; 12(3): 168 doi: 10.5812/hepatmon.5124
6
Corinne Buchanan, Tram T. Tran. Current Status of Liver Transplantation for Hepatitis B VirusClinics in Liver Disease 2011; 15(4): 753 doi: 10.1016/j.cld.2011.08.011
7
H. Miyaaki, Y. Tamada, K. Hayashi, N. Taura, S. Miuma, H. Shibata, A. Soyama, M. Hidaka, M. Takatsuki, S. Eguchi, K. Nakao. Recurrent Hepatitis B and D Virus Infection in a Liver Transplant RecipientTransplantation Proceedings 2017; 49(1): 175 doi: 10.1016/j.transproceed.2016.11.010
8
Arianeb Mehrabi, Majid Esmaeilzadeh, Hamidreza Fonouni, Mohammadreza Hafezi, Nuh N. Rahbari, Mohammad Golriz, Ali Majlesara, Morva Tahmasbi Rad, Mahmoud Sadeghi, Jan Schmidt, Tom M. Ganten. The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantationLangenbeck's Archives of Surgery 2012; 397(5): 697 doi: 10.1007/s00423-011-0795-6
9
E. Magiorkinis, D. Paraskevis, I.D. Pavlopoulou, M. Kantzanou, C. Haida, A. Hatzakis, I.N. Boletis. Renal transplantation from hepatitis B surface antigen (HBsAg)‐positive donors to HBsAg‐negative recipients: a case of post‐transplant fulminant hepatitis associated with an extensively mutated hepatitis B virus strain and review of the current literatureTransplant Infectious Disease 2013; 15(4): 393 doi: 10.1111/tid.12094
10
Lucas Carvalho Dantas, Tércio Genzini, Marcelo Perosa de Miranda, Regina Gomes dos Santos, Nilton Ghiotti de Siqueira, Judith Weirich, Cirley Maria de Oliveira Lobato. Liver transplantation in a patient with hepatitis B, C and D coinfection associated with hepatocellular carcinoma: a management strategy for a rare condition. Case reportSao Paulo Medical Journal 2015; 133(6): 525 doi: 10.1590/1516-3180.2015.8881501
11
Jian Yong Lei, Wen Tao Wang, Lu Nan Yan. Hangzhou criteria for liver transplantation in hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology 2014; 26(2): 200 doi: 10.1097/MEG.0b013e3283652b66
12
Ming-Tsung Lin, Yi-Hao Yen, Ming-Chao Tsai, Po-Lin Tseng, Kuo-Chin Chang, Cheng-Kun Wu, Tsung-Hui Hu, Seung Up Kim. Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World PracticePLOS ONE 2016; 11(11): e0165416 doi: 10.1371/journal.pone.0165416
13
Clinical NewsBritish Journal of Hospital Medicine 2010; 71(5): 250 doi: 10.12968/hmed.2010.71.5.47903
14
Ali Yahyazadeh, Susanne Beckebaum, Vito Cicinnati, Christian Klein, Andreas Paul, Andreas Pascher, Ruth Neuhaus. Efficacy and safety of subcutaneous human HBV-immunoglobulin (Zutectra®) in liver transplantation: an open, prospective, single-arm phase III studyTransplant International 2011; 24(5): 441 doi: 10.1111/j.1432-2277.2011.01222.x
15
Yanyi Ren, Zhaozhe Liu, Zhenyu Ding, Xiaodong Xie. Autologous cytokine-induced killer cells in equal to liver protectant in a patient with metastatic rectal cancerThe Chinese-German Journal of Clinical Oncology 2013; 12(7): 350 doi: 10.1007/s10330-013-1174-2
16
Amir Kasraianfard, Kymberly D. Watt, Lance Lindberg, Sophoclis Alexopoulos, Nima Rezaei. HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver TransplantationInternational Reviews of Immunology 2014; : 1 doi: 10.3109/08830185.2014.921160